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Toronto, Ontario, Canada; and Tel Aviv, IsraelObjectives The aim of the study was to determine native coronary artery patency 1 year after
coronary artery bypass grafting and to identify clinical and angiographic predictors for the
development of a chronic total occlusion (CTO).
Background In contrast to the large body of information regarding graft patency, data regarding
atherosclerosis progression and vessel patency in surgically bypassed native coronary arteries
are less clear.
Methods Of the 440 patients who underwent 1-year follow-up angiography as part of the multicenter
RAPS (Radial Artery Patency Study), included in our study were 388 patients (88%) for whom
angiograms were available for review. Angiograms were reviewed for native coronary artery patency in
an independent blinded manner.
Results On the pre-operative angiogram, CTO of at least 1 native coronary vessel was demonstrated
in 240 patients (61.9%) having 305 occluded vessels. At 1 year after coronary artery bypass grafting,
at least 1 new native coronary artery CTO occurred in 169 patients (43.6%). In 7.5% of patients, the
native artery and the graft supplying that territory were both occluded. A new CTO was almost 5 times
more likely to occur in coronary vessels with a pre-operative proximal stenosis >90% compared with
vessels with proximal stenosis <90% (45.5% vs. 9.5%, respectively, p < 0.001). Patients with a new CTO
had signiﬁcantly more baseline Canadian Cardiovascular Society class 4 angina compared with
patients without a new CTO. A new CTO was less likely to occur in the left anterior descending artery
(18.4%), supplied by the left internal thoracic artery. When comparing radial artery and saphenous
vein grafts, neither the type of graft nor graft patency had any association with native coronary artery
occlusion.
Conclusions CTO of surgically bypassed coronary arteries 1 year after coronary artery bypass grafting
is extremely common. (J Am Coll Cardiol Intv 2014;7:761–7) ª 2014 by the American College of
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762Coronary artery bypass grafting (CABG) remains the most
common revascularization mode for patients with multi-
vessel coronary artery disease. Several studies have demon-
strated better long-term patency and improved survival after
CABG with internal thoracic artery (ITA) grafts (1–4).
Therefore, the left ITA has traditionally been used to bypass
the anterior coronary circulation. Furthermore, the multi-
center RAPS (Radial Artery Patency Study) demonstrated
that radial artery grafts are associated with a lower rate of
graft occlusion at 1 year than are saphenous vein grafts
(SVGs) (5). These ﬁndings have been supported by several
smaller studies (6–8). Unlike the large body of information
regarding graft patency, data regarding atherosclerosis pro-
gression in surgically bypassed native coronary arteries are
less clear and derived mainly from studies conducted >3
decades ago, before the use of the left ITA and radial grafts
and widespread statin use. The available studies have
demonstrated accelerated atherosclerosis progression thatAbbreviations
and Acronyms
CABG = coronary artery
bypass grafting
CCS = Canadian
Cardiovascular Society
CTO = chronic total occlusion
ITA = internal thoracic artery
LAD = left anterior
descending artery
LCX = left circumﬂex artery
PCI = percutaneous coronary
intervention
RCA = right coronary artery
SVG = saphenous vein graftwas as much as 10 times as fre-
quent in bypassed arteries as in
comparable arteries that were not
bypassed (9–13). Nevertheless, in
most of those studies, follow-up
angiograms were obtained several
years after CABG using saphe-
nous vein bypass grafts, and data
regarding native coronary artery
disease progression and especially
the rate of postoperative com-
plete occlusion are not clear. The
status of the native coronary cir-
culation and especially the prev-
alence of chronic total occlusion
(CTO) in patients post-CABG
are clinically important whenconsidering revascularization after graft failure. A recent
multicenter registry of CTO percutaneous coronary inter-
vention (PCI) demonstrated lower technical success rates in
patients with previous CABG compared with patients
without previous CABG (14). The purposes of the current
study were to determine native coronary artery patency
1 year after CABG and to identify clinical and angiographic
risk factors for native coronary vessel occlusion using data
from the RAPS database.
Methods
Study population. The study population consisted of pa-
tients enrolled in the multicenter RAPS between November
1996 and January 2001, which mandated 1-year follow-up
angiography. The primary objective of the RAPS was to
compare the longitudinal patency of the radial artery and
saphenous vein. Details of the study protocol were previously
published (5). Brieﬂy, patients enrolled were younger than80 years of age undergoing nonemergent primary isolated
CABG for triple-vessel disease with an estimated left ven-
tricular ejection fraction of >35%. The left ITA was used to
bypass the left anterior descending artery (LAD) circulation,
and patients were randomly assigned to 1 of 2 graft strate-
gies: (1) the radial artery was used to graft the left circumﬂex
artery (LCX) territory and an SVG was used for the right
coronary artery (RCA) or (2) the radial artery was directed to
the RCA territory and an SVG was used for the LCX
system. The target vessels for the radial artery and study
saphenous vein were deemed to be at least 1.5 mm in
diameter with a proximal stenosis of at least 70% by visual
inspection. The primary study endpoint was the proportion
of radial arteries and study saphenous veins that were
completely occluded at 1 year after surgery. Complete oc-
clusion was deﬁned as the absence of opaciﬁcation of the
target coronary artery (i.e., Thrombolysis In Myocardial
Infarction ﬂow grade 0). Of the 440 participants who un-
derwent 1-year follow-up angiography, included in our study
were only 388 patients for whom coronary angiograms were
still available for review at the time of our study.
Study endpoints. The primary endpoint of our study was
the occurrence of a new complete native coronary artery
occlusion at 1 year post-surgery. In the present study, we
focused only on the 3 main coronary vessels (i.e., LAD,
LCX, and RCA). Therefore, diagonal branches, even if
grafted, were excluded.
Perioperative management. The surgical technique used in
this study was previously described (5). Patients were given
325 mg of aspirin daily within 6 h postoperatively and
continued indeﬁnitely. Oral nifedipine was initiated on the
ﬁrst postoperative day and continued to 6 months for pro-
phylaxis against radial artery spasm.
Follow-up angiography. Patients underwent follow-up cor-
onary angiography 8 to 12 months after surgery. The protocol
required injection of each study graft with at least 2 orthogonal
views. Analysis of baseline angiograms were conducted at
enrollment to the RAPS by the local study investigators. The
1-year angiograms were reviewed by 2 interventional cardi-
ologists who were blinded to the baseline interpretation.
Coronary arteries were determined to be occluded if no
contrast dye injected into it opaciﬁed the distal vessel (i.e.,
Thrombolysis In Myocardial Infarction ﬂow grade 0).
Ethical considerations. Institutional research ethics board
approval was obtained for this study. All patients provided
informed consent.
Statistical analysis. The primary objective was to determine
the patency of native coronary arteries at 8 to 12 months
after CABG and to identify clinical and angiographic
predictors of CTO. Student’s t test was used to compare
continuous variables with creatinine normalized by a log
transformation. A chi-square, Fisher exact, or a Mann-
Whitney U test was used where appropriate to compare
categorical variables between patients with and without new
Table 2. Native Coronary Artery CTO Prevalence and
Distribution on the Preoperative Angiogram and at 1 Year
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763coronary CTOs. Statistical signiﬁcance was assumed for
p < 0.05.Pre-operative angiogram
Total no. of patients with 1 CTO 240 (61.9)
Total of CTO vessels 305
LAD 73 (18.8)
LCX 76 (19.5)
RCA 156 (40)
1-year angiogram
Patients with 1 new CTO 169 (43.6)
Patients with 1 new CTO 133 (34.3)
Patients with 2 new CTOs 29 (7.5)
Patients with 3 new CTOs 7 (1.8)
New CTO in native coronary vessels 212
LAD 58 (27.4)
LCX 72 (34.0)
RCA 82 (38.6)
Total CTO in native coronary vessels
LAD 131 (33.8)
LCX 148 (38.1)
RCA 238 (61.35)
Values are n (%).
CTO ¼ chronic total occlusion; LAD ¼ left anterior descending artery; LCX ¼ left circumﬂex
artery; RCA ¼ right coronary artery.Results
Patient characteristics. The 388 patients for whom 1-year
post-operative coronary angiograms were available had a
mean age of 60.3  8.5 years and included 338 males
(87.1%) (Table 1). This study was representative of the
overall RAPS population, without any signiﬁcant dif-
ferences in baseline characteristics (5). CTO of at least
1 native coronary artery on the preoperative coronary
angiogram was relatively common, with 240 (61.9%) of
patients having 305 occluded vessels (Table 2, Fig. 1).
The RCA was by far the most commonly occluded vessel
on the preoperative angiogram (40%), followed by the
LCX (19.5%) and LAD (18.8.%). The primary endpoint
of at least 1 new complete native coronary artery occlusion
at 1 year post-surgery occurred in 169 patients(43.6%)
who had 212 new occluded coronary vessels, with the
RCA still being the most commonly newly occluded
vessel (38.6%, 34%, and 27.4% for the RCA, LCX, and
LAD, respectively).Table 1. Baseline Characteristics of Patients With or Without a
New CTO at 1 Year Post-CABG
Characteristic
All
(N ¼ 388)
New CTO
(n ¼ 169)
No New CTO
(n ¼ 219) p Value
Age, yrs 60.3  8.5 60.8  8.3 60  8.6 0.94
Age >70 yrs 60 (15.5) 27 (16) 33 (15)
Male sex 338 (87.1) 145 (85.8) 193 (88.1) 0.5
Preoperative MI 177 (45.6) 78 (46.2) 99 (40.2) 0.85
Nonelective surgery 125 (32.2) 63 (37.3) 62 (28.3) 0.06
Current smoker 68 (17.5) 29 (17.2) 39 (17.8) 0.87
Hypertension 180 (46.4) 81 (47.9) 99 (45.2) 0.59
Hypercholesterolemia 268 (69.0) 117 (69.2) 151 (68.9) 0.95
PVD history 27 (7.0) 13 (7.7) 14 (6.4) 0.62
Diabetes mellitus 106 (27.3) 45 (26.6) 61 (27.9) 0.79
Insulin treatment 20 (5.2) 6 (3.6) 14 (6.4) 0.21
CCS class of angina 0.0009
1 5 (1.3) 2 (1.2) 3 (1.4)
2 95 (24.5) 33 (19.5) 62 (28.3)
3 191 (49.2) 77 (45.6) 114 (52.0)
4 97 (25.0) 57 (33.7) 40 (18.3)
Left ventricular grade 0.92
1 191 (49.2) 91 (53.8) 100 (45.7)
2 192 (49.5) 77 (45.6) 115 (52.5)
3 4 (1.0) 1 (0.6) 3 (1.4)
4 1 (0.3) 0 1 (0.4)
Creatinine, mmol/l 89.7  19.3 93.1  21.5 92  17.3 0.08
Values are mean  SD or n (%).
CABG ¼ coronary artery bypass grafting; CCS ¼ Canadian Cardiovascular Society; CTO ¼
chronic total occlusion; MI ¼ myocardial infarction; PVD ¼ peripheral vascular disease.Clinical predictors for native coronary artery occlusion.
Although most baseline characteristics, including all the
traditional cardiovascular risk factors, were comparable be-
tween the 2 groups, patients with a new native coronary
vessel occlusion more frequently had Canadian Cardiovas-
cular Society (CCS) class 4 angina pectoris (Table 1). There
was also a trend toward a higher rate of nonelective surgery
and higher serum creatinine levels among patients with a
new native coronary artery occlusion. Sixty-eight percent of
patients were treated with a statin at 1 year post-surgery.
There was no signiﬁcant difference in statin therapy rate
between patients with or without a new native coronary
vessel occlusion (66.9% and 68.9%, respectively, p ¼ 0.66).
Angiographic predictors of native coronary artery
occlusion. A new native coronary artery occlusion was
almost 5 times more likely to occur in vessels with a proximal
stenosis >90% by visual inspection on the pre-operative
angiogram compared with vessels with a proximal stenosis
<90% (Fig. 2). Furthermore, complete occlusions were more
common in vessels bypassed by either an SVG or radial
artery grafts (29.2% and 27.4%, respectively) compared
with the LAD (18.4%) that was grafted by the left ITA
(Fig. 3). In a comparison of vessels grafted by an SVG or
radial artery, there was no association between graft type
and native coronary artery patency.
Similar to the original RAPS results, radial artery grafts
were associated with a lower rate of graft occlusion at 1 year.
In our cohort, complete graft occlusion occurred in 12.9%
Figure 1. Native Coronary Artery Patency Pre-CABG and at 1-Year Follow-
up
CTOs were most common in the RCA pre-CABG and lowest in the LAD. New
CTOs also were more frequent in the RCA during the ﬁrst year. LAD and CX
occlusions were similar pre-CABG and at 1 year. CABG ¼ coronary artery
bypass grafting; CTO ¼ chronic total occlusion; CX ¼ left circumﬂex artery;
LAD ¼ left anterior descending artery; RCA ¼ right coronary artery.
Figure 3. New Native Coronary Artery Occlusion at 1 Year After CABG
According to the Graft Type
The risk of the development of a new CTO at 1 year was signiﬁcantly lower in
the LAD grafted by the left internal thoracic artery (LITA) compared with the
CX and RCA that were grafted by either a radial artery graft or saphenous vein
graft (SVG) (p ¼ 0.01 for a comparison of radial artery and LITA graft; p ¼
0.0025 for a comparison of an SVG and LITA graft). There were no differences
in native artery patency in arteries grafted with an SVG compared with the
radial artery (p ¼ 0.7). Other abbreviations as in Figure 1.
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764of SVGs and 8% of radial artery grafts (50 of 388 vs. 31
of 388). To assess a possible association between graft
and new native vessel occlusion, grafts initially used to
bypass a completely occluded coronary artery were excluded.
Although patent grafts appeared to be associated with an
increased risk of native coronary artery occlusion at 1 year,
this association was not found to be statistically signiﬁcantFigure 2. New Native Coronary Artery CTO at 1 Year According to
Pre-Operative Stenosis Severity
A preoperative stenosis of >90% at baseline was associated with a signiﬁ-
cantly increased risk of progression to CTO at 1 year compared with preop-
erative stenosis <90% (p < 0.0001). CTO ¼ chronic total occlusion.(p ¼ 0.26) (Fig. 4). In 29 (7.5%) patients, a complete oc-
clusion of both the bypassed native coronary artery and its
graft was demonstrated on the 1-year coronary angiogram,
causing the absence of antegrade distal blood ﬂow to this
territory.Discussion
This clinical study included 388 patients who underwent
bypass surgery using the same surgical technique and who
underwent coronary angiography at 1 year as part of the
study protocol. It was designed to assess native coronary
artery patency at 1 year post-CABG, based on the multi-
center RAPS database. We demonstrated that a complete
occlusion of a native coronary vessel is common among
the surgical population on both the pre- and postoperative
angiograms with a new CTO of a native coronary artery
developing in >40% of post-CABG patients at 1 year.
Predictors of a new coronary artery occlusion included CCS
class 4 angina and a proximal stenosis of >90% on the pre-
operative angiogram.
Disease progression in surgically bypassed coronary ar-
teries has been the subject of several studies. A study of
85 men who had undergone CABG identiﬁed bypass grafts
placed in 37 native arteries with mild atherosclerosis and
93 coronary vessels with mild atherosclerosis for which a
bypass graft had not been placed (10). Progression of
atherosclerosis, deﬁned as further loss of at least 25% of the
Figure 4. Relationship Between New Native Coronary Artery Occlusion and
Graft Patency at 1 Year
Grafts used to bypass a coronary artery with CTO pre-CABG were excluded
from this analysis. Patent grafts were associated with a modest but nonsig-
niﬁcant increase in native coronary artery CTO at 1 year (p ¼ 0.26). Abbrevi-
ations as in Figure 1.
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765lumen, during an average follow-up period of 3 years was
>10 times as frequent in bypassed arteries with minimal
atherosclerosis as in comparable arteries that were not
bypassed (38% vs. 3%). Another study of 109 patients
evaluated 5 years after surgery demonstrated that the risk of
disease progression was 3 to 6 times higher in grafted
compared with ungrafted arteries (11). For grafted arteries,
the risk of progression was twice as high in arteries with
patent grafts compared with those with closed grafts. The
majority (78%) of grafted arteries with progression were
completely occluded. These ﬁndings were supported by
another study of 82 patients examined 10 years after
SVG bypass surgery (9). However, although these studies
consistently demonstrated enhanced atherosclerosis in the
bypassed coronary vessels, their results are limited by the
relatively small population, repeat angiography was not
mandated by protocol, angiographic follow-up was 3 to 10
years post-surgery, and all studies were performed 3 decades
ago. Since that time, several aspects of CABG have changed
dramatically, including surgical techniques such as the
routine use of the left ITA to bypass the anterior coronary
circulation and the introduction of radial artery grafts as
well as adjuvant medical therapy such as potent statins and
antiplatelet agents. Accelerated disease progression was
demonstrated in 2 more recent studies (12,13). However, in
these particular studies, follow-up coronary angiograms were
not obtained routinely but only when symptoms developed
in patients. Therefore, there may have been a selection bias
in which only the patients with more severe coronary disease
were evaluated.The accelerated atherosclerosis and the relatively high
rate of native coronary occlusion during the ﬁrst operative
year are clinically important when considering revasculari-
zation in post-CABG patients after graft failure. We
demonstrated an occlusion of both the bypassed native
coronary artery and its graft in 7.5% of patients. However,
this rate is expected to increase later in the postopera-
tive period due to further progression of atherosclerosis
in the native coronary vessels and anticipated graft failure.
Re-achieving coronary revascularization in post-CABG
patients with CTO is challenging and associated with lower
success rates. In a recent multicenter registry of CTO PCI,
previous CABG was independently associated with lower
technical success rate (odds ratio: 0.49; 95% conﬁdence
interval: 0.35 to 0.70; p < 0.001) (14). These ﬁndings
highlight the fact that although coronary revascularization
with CABG provides signiﬁcant prognostic and symp-
tomatic beneﬁt, it is also associated with increased coronary
disease atherosclerosis burden and limited future PCI
options.
The mechanisms leading to disease progression and
CTO formation in surgically bypassed native coronary ar-
teries are not fully explained. Similar to previous reports, we
demonstrated that the prevalence of all traditional cardio-
vascular risk factors, including diabetes mellitus, was similar
among patients with and without new coronary artery oc-
clusion at 1 year, suggesting that this process differs in
some respects from the atherosclerosis in nonbypassed ves-
sels. One plausible explanation is ﬂow competition between
the native vessel and the graft (9–13). High competitive
ﬂow has been demonstrated to result in low and oscillatory
wall shear stress (15,16). These alterations in wall shear
stress have been linked to enhanced coronary artery disease
progression through marked impairment of endothelial
function (15–17). Low wall shear stress up-regulates endo-
thelin-1 (15,18) and thrombomodulin (19), while down-
regulating nitric oxide and prostacyclin production (15,18)
by endothelial cells. These alterations in endothelium-
derived vasoactive agents alter vascular tone and inﬂuence
atherogenic processes by promoting smoothmusclemigration
and proliferation (20), enhanced matrix breakdown (21),
increased endothelial permeability to lipoproteins and
collagen depositions (22), as well as leukocyte (23) and platelet
(24) adhesion. These processes result in excessive remodeling,
increased wall thickening, and enhanced atherosclerosis
(25,26). These vascular changes further contribute to the
underlying ﬂow stasis and procoagulant state caused by the
oscillatory wall shear stress (27,28), the nonlaminar ﬂow,
and the endothelial dysfunction, which can ultimately lead
to atherothrombosis and coronary artery occlusion at the
lesion site.
In the current study, the strongest predictor of a new
native coronary vessel occlusion was the presence of CCS
class 4 angina pectoris before surgery. Furthermore, a new
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766native coronary artery occlusion was almost 5 times more
likely to occur in vessels with a proximal stenosis >90% on
the pre-operative angiogram compared with vessels with
proximal stenosis <90%. These ﬁndings suggest a positive
correlation between baseline coronary artery disease severity
and enhanced atherosclerosis, an association reported in
previous studies (11,12).
Several studies, including the RAPS, have demonstrated
that for all graft types, graft patency was lower in the absence
of severe native vessel stenosis (5,29,30). This inverse asso-
ciation remained when native vessel patency was examined,
with signiﬁcantly more severe disease progression in a vessel
bypassed by a patent compared with an occluded graft
(11,13). In our study, patent radial artery or vein grafts
appeared to be associated with an increased risk of native
coronary artery occlusion at 1 year. However, this association
was not statistically signiﬁcant. This may be explained by the
relatively low incidence of graft occlusion within the ﬁrst
year among patients included in the RAPS (8.2% for radial
artery grafts and 13.6% for SVGs). Native coronary occlu-
sion was signiﬁcantly less frequent in the LAD that was
bypassed by the left ITA compared with the LCX and RCA
that were bypassed by either a radial artery or an SVG. This
may be attributed to the larger vessel size of the LAD, which
may decrease the risk of complete occlusion. Another po-
tential explanation is the ﬂow rate in the left ITA that may
be associated with less stasis of blood through the native
coronary artery.
Study limitations. Although our study is the ﬁrst to evaluate
native coronary artery patency at 1 year post-CABG, it has
several limitations that require consideration. First, the study
was based on the multicenter RAPS database. However, of
the 440 RAPS patients who underwent 1-year follow-up
angiography, our study included 388 patients (88%) for
whom coronary angiograms were still available for review.
Similar clinical and angiographic parameters in the 2 cohorts
suggest that our cohort was very representative of the orig-
inal RAPS. Although our study represents the largest patient
cohort to date evaluated for native vessel patency after bypass
surgery, our ﬁndings may still be limited by the relatively
small sample size. Third, the primary endpoint was the
occurrence of a new complete native coronary artery occlu-
sion at 1 year post-CABG, and it did not include other
measurements of coronary disease progression or clinical
outcomes. The development of a CTO from a previously
patent coronary artery is a critical step in coronary artery
disease progression because revascularization by PCI of a
CTO is much more challenging and associated with
signiﬁcantly lower success rates and a higher risk of peri-
procedural complications (14). Fourth, our study did not
perform angiographic quantitative analysis of native coronary
vessel size or various lesion characteristics such as length
and distance of the lesion relative to the graft site, param-
eters that may affect the risk of vessel occlusion.Conclusions
Even in contemporary cardiovascular surgical practice, the
development of a new CTO of bypassed native coronary
artery is common in post-CABG patients even within the
ﬁrst postoperative year. This process, which is secondary
to enhanced coronary atherosclerosis, may result in the
recurrence of symptoms that are particularly challenging for
revascularization.
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